Figure 4: IHC analysis of GPR155 expression in tissues of representative patients with GC and the survival curve of patients with Stage II/III GC.
From: GPR155 Serves as a Predictive Biomarker for Hematogenous Metastasis in Patients with Gastric Cancer
(A) GPR155 staining intensity of GC tissues was generally low compared with the corresponding noncancerous mucosae. GPR155 staining intensity correlated significantly with synchronous and metachronous hematogenous metastasis. (B) There was not significant difference in overall survival between low GPR155 and high GPR155 groups with Stage II/III GC. (C) There was no significant difference in disease-free survival between the low GPR155 and high GPR155 groups with Stage II/III GC. Abbreviations: T; tumor tissue, N; non-cancerous component, GC; primary gastric cancer tissue, Hem/Hem-rec; hematogenous metastasis/recurrence.
